Shaping the future
of animal health
Products

RILEXINE® (cephalexin) Chewable Tablets for Dogs

The first veterinary FDA-approved cephalexin makes treating superficial pyoderma (caused by Staphlococcus pseudintermedius) feel more like giving a treat.

  • Proven palatability means at-home dosing takes less effort (and trickery) by your client – for the duration of your treatment plan.
  • Provides you with an effective treatment option that may help improve compliance.
  • Scored tablets offer dosages that are FDA-approved for your canine patients. No more hassling with bitter-tasting human cephalexin capsules:
    • Three sizes of tablets and scoring make it easier to prescribe the exact dose your canine patient needs.
    • Scored tablets are ideal for BID dosing; can help minimize the daily cost of therapy.
  • By combining palatability with canine-friendly dosing, it’s truly your best value.

Studies confirm RILEXINE® (cephalexin) Chewable Tablets are the tasty solution for improved compliance.

  • Palatability research demonstrates what matters most: dogs jump at the chance to take RILEXINE Chewable Tablets.1, 2
  • In one study, over 80% of dogs voluntarily accepted RILEXINE Chewable Tablets.1
  • In a second study, RILEXINE Chewable Tablets scored higher than 78% on overall palatability.2

RILEXINE (cephalexin) Chewable Tablets are more than palatable – they’re effective.

  • RILEXINE Chewable Tablets are effective against Staphylococcus pseudintermedius – the organism responsible for approximately 90% of canine pyoderma cases.3, 4

Contraindicated in dogs with a known allergy to penicillins or cephalosporins. For oral use in dogs only. Not for use in humans. Individuals sensitive to penicillins or cephalosporins should avoid contact of the product with the skin and mucous membranes. Do not prescribe in the absence of a proven or strongly suspected bacterial infection. Safety in breeding, pregnant, or lactating bitches has not been evaluated. The most common adverse reactions in dogs include diarrhea, vomiting, anorexia and lethargy. For complete product information refer to the product insert.

References:

  1. Sponsor study #646.06-000-30013 Palatability of 646.06 (Cephalexin monohydrate) in client owned dogs, 2007.
  2. Sponsor study #646.06-000-30014 Palatability of 646.06 (Cephalexin monohydrate) in client owned dogs, 2007.
  3. Hannigan M. Pyoderma. In: Cote E, ed. Clinical Veterinary Advisor Dogs and Cats. St. Louis, MO: Mosby, Inc; 2007:930–932.
  4. Hnilica KA, Bacterial skin diseases. In: Small Animal Dermatology: A Color Atlas and Therapeutic Guide. 3rd ed. St. Louis, MO: Saunders; 2011:37-82.
Ordering Information

Available Sizes

Description Product Number
150 mg – 100 count  07620
300 mg – 100 count  07630
600 mg – 100 count  07640
RILEXINE<sup>®</sup> (cephalexin) Chewable Tablets for Dogs

Click image to enlarge

RILEXINE<sup>®</sup> (cephalexin) Chewable Tablets for Dogs
FAQs

What is the flavoring of RILEXINE® (cephalexin) Chewable Tablets?

The RILEXINE Tablets are flavored with a natural poultry-liver base.

Can RILEXINE Tablets be used with cats?

RILEXINE Tablets are labeled for use in dogs only. 

People who viewed this product also viewed